Videos

Educated Patient® Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session: November 13, 2021

November 13th 2021

View the full CURE Educated Patient Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session on demand.

The Importance of Support Networks for HER2-positive Breast Cancer

November 12th 2021

Julie Fisher, M.D., has a conversation with patient Jocelyn Mueller about the importance of good support networks when living with HER2-positive breast cancer.

The Patient’s Perspective on how Treatment for HER2-positive Breast Cancer impacts Daily Life

November 12th 2021

Jocelyn Mueller details how chemotherapy treatments have affected her daily life and her decision to receive treatment through a port.

Underrepresentation in Clinical Trials: The Racial Disparities of Breast Cancer Research

November 10th 2021

Sheila McGlown provides insight into the underrepresentation of women of color in clinical trials for breast cancer and discusses reasons for these disparities.

Addressing Racial Disparities in Breast Cancer

November 10th 2021

The panel elaborates on the racial disparities in the care of breast cancer and the need for systemic change to address these disparities.

Educated Patient® Webinar: Stomach Cancer 101 Series: Part III – Survivorship and Mental Health

November 8th 2021

View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part III – Survivorship and Mental Health

Adopting Precision Medicine in NSCLC

November 5th 2021

Take-home messages from a discussion on the use of biomarker testing, and newer, novel-based strategies to treat patients with non-small cell lung cancer.

Rechallenging Therapy in NSCLC

November 5th 2021

Preferences for rechallenging patients with non-small cell lung cancer with immunotherapy based on previous experiences in terms of treatment-related side effects.

Assessing HER2-positive Breast Cancer Treatment Responses and Managing Side Effects

November 5th 2021

Julie Fisher, MD, explains how she assesses HER2-positive breast cancer patients for treatment response, what side-effects can occur and how they can be managed.

NSCLC: Preparing Patients for Treatment-Related Side Effects

November 5th 2021

Strategies that can help various health care professionals best mitigate or manage side effects associated with newer treatments in non-small cell lung cancer, such as immunotherapy.

Receiving Treatment for HER2-positive Breast Cancer: The Patient Experience

November 5th 2021

Jocelyn Mueller describes the preoperative treatments she has received for HER2-positive breast cancer, and the questions she had for her medical care team.

Racial Disparities Faced by Women of Color with Breast Cancer

November 4th 2021

Sheila McGlown identifies the racial disparities that exist in the treatment of breast cancer, particularly those faced by women of color, and discusses reasons why these disparities may exist.

Finding a Support Group for Metastatic Breast Cancer Patients

November 4th 2021

The panel discusses strategies for locating appropriate support groups for patients with metastatic breast cancer.

Available Treatment Options for von Hippel-Lindau Disease

November 3rd 2021

CURE spoke with Stacy Lloyd, board member of the VHL Alliance, about the treatment options for patients with VHL.

The Basics of von Hippel-Lindau Disease

November 3rd 2021

CURE spoke with Stacy Lloyd, board member of the VHL Alliance, to better understand VHL and its impact on cancer.

‘What Is a Hassle Anymore?’ Survivor Highlights Cancer’s Platinum Lining

November 2nd 2021

After missing his flight, voice actor Rob Paulsen recorded a vlog in the airport where he discusses the “platinum lining” behind his cancer diagnosis when it comes to everyday hassles like travel.

Discussing Hereditary Cancer, VHL Disease With One’s Family

November 2nd 2021

As a part of its “Speaking Out” video series, CURE spoke with Stacy Lloyd on behalf of the VHL Alliance, about discussing hereditary cancer with family members and how a diagnosis can lead to earlier surveillance for the disease.

Disparities in von Hippel-Lindau Disease

November 2nd 2021

CURE spoke with Stacy Lloyd, board member of the VHL Alliance, about disparities seen in VHL and its patient population.

Patient Resources and Support for von Hippel-Lindau Disease

November 2nd 2021

CURE spoke with Stacy Lloyd, board member of the VHL Alliance, about VHL as a rare disease and resources available for patients to learn more.

Shared Decision-Making in NSCLC

October 29th 2021

The significance of shared decision-making between patients and lung oncologists when considering a novel-based therapy as treatment for non-small cell lung cancer.

HER2-positive Breast Cancer: Post-Operative Therapies

October 29th 2021

Dr. Julie Fisher details the therapies used for HER2-positive breast cancer in the post-operative setting, including newly available treatment options, and reviews data supporting the choice of therapy for each patient.

Immunotherapy for Patients With NSCLC

October 29th 2021

Considerations for treating patients with non-small cell lung cancer with single-agent immunotherapy vs chemoimmunotherapy.

HER2-positive Breast Cancer: Pre-operative Therapies

October 29th 2021

Dr. Julie Fisher, an expert oncologist, describes the range of treatment options for HER2-positive breast cancer in the pre-operative setting.

Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options

October 28th 2021

View the full CURE® Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options on demand.

Lung Cancer Heroes Awards 2021

October 28th 2021

Watch the entire Lung Cancer Heroes® presentation here!

The Importance of Shared Decision-Making in Receiving Molecular Testing for NSCLC

October 28th 2021

Stephen Liu, MD, and Danielle Hicks clarify the importance of involving patients and caregivers in discussions about non-small cell lung cancer molecular testing.

Targeted Therapies in Non-Small Cell Lung Cancer

October 28th 2021

Thought leaders give an overview on KRAS-mutated non-small cell lung cancer and the treatment options available.

Importance of Support Groups in Metastatic Breast Cancer

October 27th 2021

Lisa Laudico provides insight into the value of support groups in metastatic breast cancer.

Self-Inventory for Metastatic Breast Cancer

October 27th 2021

Julie Larson, LCSW, discusses the concept of self-inventory and questions patients may ask themselves to evaluate their health.

Curing Stomach Cancer Month

October 25th 2021

Debbie's Dream Foundation wants every state to recognize November as Curing Stomach Cancer Month, so we've made it easy for you to help make this happen.